Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Search

Page Path
HOME > Search
4 "Jong-Soo Lee"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Articles
Interactome Analysis Reveals that Heterochromatin Protein 1γ (HP1γ) Is Associated with the DNA Damage Response Pathway
Hongtae Kim, Jae Duk Choi, Byung-Gyu Kim, Ho Chul Kang, Jong-Soo Lee
Cancer Res Treat. 2016;48(1):322-333.   Published online March 6, 2015
DOI: https://doi.org/10.4143/crt.2014.294
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
Heterochromatin protein 1γ (HP1γ) interacts with chromosomes by binding to lysine 9-methylated histone H3 or DNA/RNA. HP1γ is involved in various biological processes. The purpose of this study is to gain an understanding of how HP1γ functions in these processes by identifying HP1γ-binding proteins using mass spectrometry.
Materials and Methods
We performed affinity purification of HP1γ-binding proteins using G1/S phase or prometaphase HEK293T cell lysates that transiently express mock or FLAG-HP1γ. Coomassie staining was performed for HP1γ-binding complexes, using cell lysates prepared by affinity chromatography FLAG-agarose beads, and the bands were digested and then analyzed using a mass spectrometry.
Results
We identified 99 HP1γ-binding proteins with diverse cellular functions, including spliceosome, regulation of the actin cytoskeleton, tight junction, pathogenic Escherichia coli infection, mammalian target of rapamycin signaling pathway, nucleotide excision repair, DNA replication, homologous recombination, and mismatch repair.
Conclusion
Our results suggested that HP1γ is functionally active in DNA damage response via proteinprotein interaction.

Citations

Citations to this article as recorded by  
  • Inhibition of annexin A7 suppresses senescence‐associated heterochromatin foci formation and senescence through the AMPK/mTOR pathway in human dermal fibroblasts
    Nan Li, Xiaomeng Yan, Xiaoling Cui, Congyao Zhao, Zhaomin Lin, Junying Miao
    Journal of Cellular Biochemistry.2023; 124(10): 1603.     CrossRef
  • Clinicopathological significance of CBX3 in colorectal cancer: An intensive expression study based on formalin‐fixed and paraffin‐embedded tissues
    Hai Wang, Wenyue Zhao, Jiandong Wang, Zhiyuan Zhang
    Pathology International.2022; 72(2): 107.     CrossRef
  • Discovery, expression, cellular localization, and molecular properties of a novel, alternative spliced HP1γ isoform, lacking the chromoshadow domain
    Angela Mathison, Thiago Milech De Assuncao, Nikita R. Dsouza, Monique Williams, Michael T. Zimmermann, Raul Urrutia, Gwen Lomberk, Albert Jeltsch
    PLOS ONE.2020; 15(2): e0217452.     CrossRef
  • CBX3 Promotes Gastric Cancer Progression and Affects Factors Related to Immunotherapeutic Responses


    Hexin Lin, Jiabian Lian, Lu Xia, Guoxian Guan, Jun You
    Cancer Management and Research.2020; Volume 12: 10113.     CrossRef
  • Cbx3 inhibits vascular smooth muscle cell proliferation, migration, and neointima formation
    Cheng Zhang, Dan Chen, Eithne Margaret Maguire, Shiping He, Jiangyong Chen, Weiwei An, Mei Yang, Tayyab Adeel Afzal, Le Anh Luong, Li Zhang, Han Lei, Qingchen Wu, Qingzhong Xiao
    Cardiovascular Research.2018; 114(3): 443.     CrossRef
  • 12,043 View
  • 103 Download
  • 6 Web of Science
  • 5 Crossref
Close layer
Activation of ATM-dependent DNA Damage Signal Pathway by a Histone Deacetylase Inhibitor, Trichostatin A
Jong-Soo Lee
Cancer Res Treat. 2007;39(3):125-130.   Published online September 30, 2007
DOI: https://doi.org/10.4143/crt.2007.39.3.125
AbstractAbstract PDFPubReaderePub
Purpose

Ataxia-telangiectasia mutated (ATM) kinase regulates diverse cellular DNA damage responses, including genome surveillance, cell growth, and gene expression. While the role of histone acetylation/deacetylation in gene expression is well established, little is known as to whether this modification can activate an ATM-dependent signal pathway, and whether this modification can thereby be implicated in an ATM-mediated DNA damage response.

Materials and Methods

Formation of H2AXγ foci was examined in HeLa and U2OS cells following treatment with a histone deacetylase inhibitor, Trichostatin A (TSA). We determine an ATM-dependency of the TSA-induced DNA damage signal pathway using isogenic A-T (ATM-) and control (ATM+) cells. We monitored the phosphorylation of ATM, an ATM-downstream effector kinase, Chk2, and H2AXγ to detect the activation of the ATM-de pendent DNA damage signal pathway.

Results

Exposure of cells to TSA results in the formation of H2AXγ foci in HeLa and U2OS cells. The TSA-induced formation of H2AXγ foci occurs in an ATM-dependent manner. TSA induces phosphorylation of serine 1981 of ATM, accumulation of phosphorylated H2AX and Chk2, and formation of H2AX foci, in a manner analogous to genotoxic DNA damage.

Conclusion

In this work, we show that TSA induces a DNA damage signaling pathway in an ATM-dependent manner. These results suggest that ATM can respond to altered histone acetylation induced by the histone deacetylase inhibitor, TSA.

Citations

Citations to this article as recorded by  
  • Prime Editing: Mechanistic Insights and DNA Repair Modulation
    Astrid Mentani, Marcello Maresca, Anna Shiriaeva
    Cells.2025; 14(4): 277.     CrossRef
  • Making gene editing accessible in resource limited environments: recommendations to guide a first-time user
    Shivani Goolab, Janine Scholefield
    Frontiers in Genome Editing.2024;[Epub]     CrossRef
  • Increased DNA damage in full-grown oocytes is correlated with diminished autophagy activation
    Fei Sun, Nourhan Nashat Ali, Daniela Londoño-Vásquez, Constantine A. Simintiras, Huanyu Qiao, M. Sofia Ortega, Yuksel Agca, Masashi Takahashi, Rocío M. Rivera, Andrew M. Kelleher, Peter Sutovsky, Amanda L. Patterson, Ahmed Z. Balboula
    Nature Communications.2024;[Epub]     CrossRef
  • Phosphorylation-mediated disassembly of C-terminal binding protein 2 tetramer impedes epigenetic silencing of pluripotency in mouse embryonic stem cells
    Han-Teo Lee, Young Ah Kim, Sangho Lee, Ye-Eun Jung, Hanbyeol Kim, Tae Wan Kim, Sojung Kwak, Jaehyeon Kim, Chul-Hwan Lee, Sun-Shin Cha, Jinmi Choi, Eun-Jung Cho, Hong-Duk Youn
    Nucleic Acids Research.2024; 52(22): 13706.     CrossRef
  • Modulating CRISPR/Cas9 genome-editing activity by small molecules
    Siwei Chen, Deng Chen, Bin Liu, Hidde J. Haisma
    Drug Discovery Today.2022; 27(4): 951.     CrossRef
  • Genetic variations in ATM and H2AX loci contribute to risk of hematological abnormalities in individuals exposed to BTEX chemicals
    Samaneh Jafari Roshan, Yaser Mansoori, Seyed Reza Hosseini, Davood Sabour, Abdolreza Daraei
    Journal of Clinical Laboratory Analysis.2022;[Epub]     CrossRef
  • TSA Promotes CRISPR/Cas9 Editing Efficiency and Expression of Cell Division-Related Genes from Plant Protoplasts
    Seung Hee Choi, Myoung Hui Lee, Da Mon Jin, Su Ji Ju, Woo Seok Ahn, Eun Yee Jie, Ji Min Lee, Jiyoung Lee, Cha Young Kim, Suk Weon Kim
    International Journal of Molecular Sciences.2021; 22(15): 7817.     CrossRef
  • Targeting repair pathways with small molecules increases precise genome editing in pluripotent stem cells
    Stephan Riesenberg, Tomislav Maricic
    Nature Communications.2018;[Epub]     CrossRef
  • CCR6 Is a Predicting Biomarker of Radiosensitivity and Potential Target of Radiosensitization in Rectal Cancer
    Hui Chang, Jia-wang Wei, Ya-lan Tao, Pei-rong Ding, Yun-fei Xia, Yuan-hong Gao, Wei-wei Xiao
    Cancer Research and Treatment.2018; 50(4): 1203.     CrossRef
  • CBP/p300 acetyltransferases regulate the expression of NKG2D ligands on tumor cells
    M Sauer, M Schuldner, N Hoffmann, A Cetintas, K S Reiners, O Shatnyeva, M Hallek, H P Hansen, S Gasser, E P von Strandmann
    Oncogene.2017; 36(7): 933.     CrossRef
  • Myelodysplasia-associated mutations in serine/arginine-rich splicing factor SRSF2 lead to alternative splicing of CDC25C
    Lindsey Skrdlant, Jeremy M. Stark, Ren-Jang Lin
    BMC Molecular Biology.2016;[Epub]     CrossRef
  • Loss of H3K9me3 Correlates with ATM Activation and Histone H2AX Phosphorylation Deficiencies in Hutchinson-Gilford Progeria Syndrome
    Haoyue Zhang, Linlin Sun, Kun Wang, Di Wu, Mason Trappio, Celeste Witting, Kan Cao, Michael Shing-Yan Huen
    PLOS ONE.2016; 11(12): e0167454.     CrossRef
  • Survival of primary, but not of cancer cells after combined Plk1-HDAC inhibition
    Lisa Lange, Peter Hemmerich, Birgit Spänkuch
    Oncotarget.2015; 6(28): 25801.     CrossRef
  • A Small-Molecule Probe of the Histone Methyltransferase G9a Induces Cellular Senescence in Pancreatic Adenocarcinoma
    Yuan Yuan, Qiu Wang, Joshiawa Paulk, Stefan Kubicek, Melissa M. Kemp, Drew J. Adams, Alykhan F. Shamji, Bridget K. Wagner, Stuart L. Schreiber
    ACS Chemical Biology.2012; 7(7): 1152.     CrossRef
  • Development of a High-Content High-Throughput Screening Assay for the Discovery of ATM Signaling Inhibitors
    Catherine Bardelle, Joanna Boros
    SLAS Discovery.2012; 17(7): 912.     CrossRef
  • The MRN complex in double‐strand break repair and telomere maintenance
    Brandon J. Lamarche, Nicole I. Orazio, Matthew D. Weitzman
    FEBS Letters.2010; 584(17): 3682.     CrossRef
  • ATM modulates transcription in response to histone deacetylase inhibition as part of its DNA damage response
    Eun Ryoung Jang, Jae Duk Choi, Mi Ae Park, Gajin Jeong, Hyeseong Cho, Jong-Soo Lee
    Experimental and Molecular Medicine.2010; 42(3): 195.     CrossRef
  • Modulating Polo-Like Kinase 1 as a Means for Cancer Chemoprevention
    Travis L. Schmit, Mark C. Ledesma, Nihal Ahmad
    Pharmaceutical Research.2010; 27(6): 989.     CrossRef
  • 9,731 View
  • 75 Download
  • 18 Crossref
Close layer
Functional Link between DNA Damage Responses and Transcriptional Regulation by ATM in Response to a Histone Deacetylase Inhibitor TSA
Jong-Soo Lee
Cancer Res Treat. 2007;39(3):116-124.   Published online September 30, 2007
DOI: https://doi.org/10.4143/crt.2007.39.3.116
AbstractAbstract PDFPubReaderePub
Purpose

Mutations in the ATM (ataxia-telangiectasia mutated) gene, which encodes a 370 kd protein with a kinase catalytic domain, predisposes people to cancers, and these mutations are also linked to ataxia-telangiectasia (A-T). The histone acetylaion/deacetylation- dependent chromatin remodeling can activate the ATM kinase-mediated DNA damage signal pathway (in an accompanying work, Lee, 2007). This has led us to study whether this modification can impinge on the ATM-mediated DNA damage response via transcriptional modulation in order to understand the function of ATM in the regulation of gene transcription.

Materials and Methods

To identify the genes whose expression is regulated by ATM in response to histone deaceylase (HDAC) inhibition, we performed an analysis of oligonucleotide microarrays with using the appropriate cell lines, isogenic A-T (ATM-) and control (ATM+) cells, following treatment with a HDAC inhibitor TSA.

Results

Treatment with TSA reprograms the differential gene expression profile in response to HDAC inhibition in ATM- cells and ATM+ cells. We analyzed the genes that are regulated by TSA in the ATM-dependent manner, and we classified these genes into different functional categories, including those involved in cell cycle/DNA replication, DNA repair, apoptosis, growth/differentiation, cell- cell adhesion, signal transduction, metabolism and transcription.

Conclusions

We found that while some genes are regulated by TSA without regard to ATM, the patterns of gene regulation are differentially regulated in an ATM-dependent manner. Taken together, these finding indicate that ATM can regulate the transcription of genes that play critical roles in the molecular response to DNA damage, and this response is modulated through an altered HDAC inhibition-mediated gene expression.

Citations

Citations to this article as recorded by  
  • DNA Damage Response in Multiple Myeloma: The Role of the Tumor Microenvironment
    Takayuki Saitoh, Tsukasa Oda
    Cancers.2021; 13(3): 504.     CrossRef
  • p53/E2F1/miR-25 axis regulates apoptosis induction in glioblastoma cells: a qualitative model
    Daner A Silveira, Shantanu Gupta, José Carlos M Mombach
    Journal of Physics: Complexity.2020; 1(3): 035001.     CrossRef
  • Natural molecules as modulators of epigenetic silencing in human cells for cancer care and aging
    Aleksandra Kosianova, Vladlena Tiasto, Margarita Yatsunskaya, Yuri Khotimchenko, Alexander Kagansky
    Biological Communications.2020;[Epub]     CrossRef
  • Chromatin Modifications Associated with DNA Double-strand Breaks Repair as Potential Targets for Neurological Diseases
    Camille Brochier, Brett Langley
    Neurotherapeutics.2013; 10(4): 817.     CrossRef
  • Histone Deacetylase Regulation of ATM-Mediated DNA Damage Signaling
    K. Ted Thurn, Scott Thomas, Paromita Raha, Ian Qureshi, Pamela N. Munster
    Molecular Cancer Therapeutics.2013; 12(10): 2078.     CrossRef
  • Characterization of the transcriptome profiles related to globin gene switching during in vitro erythroid maturation
    Biaoru Li, Lianghao Ding, Wei Li, Michael D Story, Betty S Pace
    BMC Genomics.2012;[Epub]     CrossRef
  • ATM regulates a DNA damage response posttranscriptional RNA operon in lymphocytes
    Krystyna Mazan-Mamczarz, Patrick R. Hagner, Yongqing Zhang, Bojie Dai, Elin Lehrmann, Kevin G. Becker, Jack D. Keene, Myriam Gorospe, Zhenqui Liu, Ronald B. Gartenhaus
    Blood.2011; 117(8): 2441.     CrossRef
  • Dietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cells
    Praveen Rajendran, Emily Ho, David E Williams, Roderick H Dashwood
    Clinical Epigenetics.2011;[Epub]     CrossRef
  • ATM modulates transcription in response to histone deacetylase inhibition as part of its DNA damage response
    Eun Ryoung Jang, Jae Duk Choi, Mi Ae Park, Gajin Jeong, Hyeseong Cho, Jong-Soo Lee
    Experimental and Molecular Medicine.2010; 42(3): 195.     CrossRef
  • 9,741 View
  • 67 Download
  • 9 Crossref
Close layer
Review Article
DNA Damage Response Mediated through BRCA1
Eun Ryoung Jang, Jong-Soo Lee
Cancer Res Treat. 2004;36(4):214-221.   Published online August 31, 2004
DOI: https://doi.org/10.4143/crt.2004.36.4.214
PDFPubReaderePub

Citations

Citations to this article as recorded by  
  • Impact of frequent ARID1A mutations on protein stability provides insights into cancer pathogenesis
    Rajen K. Goutam, Gangtong Huang, Exequiel Medina, Feng Ding, William J. Edenfield, Hugo Sanabria
    Scientific Reports.2025;[Epub]     CrossRef
  • Stronger preference of human tumor suppressor protein BRCA1 for an open-planar Holliday junction: Insights from a combined spectroscopic and computational study
    Sahil Hasan Kabir, Vishnupriya K., Nibedita Pal
    International Journal of Biological Macromolecules.2025; 312: 144037.     CrossRef
  • BRCA1 protein dose-dependent risk for embryonic oxidative DNA damage, embryopathies and neurodevelopmental disorders with and without ethanol exposure
    Danielle M. Drake, Kian Afsharian, Benjamin Or, Aaron M. Shapiro, Michelle L. Lai, Lutfiya Miller, Peter G. Wells
    Redox Biology.2024; 70: 103070.     CrossRef
  • Exploring Evolutionary Adaptations and Genomic Advancements to Improve Heat Tolerance in Chickens
    Ali Hassan Nawaz, Phatthawin Setthaya, Chungang Feng
    Animals.2024; 14(15): 2215.     CrossRef
  • In silico screening and identifying phytoconstituents of Withania somnifera as potent inhibitors of BRCA1 mutants: A therapeutic against breast cancer
    Smita Manjari Panda, Nandeshwar, Umakanta Tripathy
    International Journal of Biological Macromolecules.2024; 282: 136977.     CrossRef
  • Genetically-regulated transcriptomics & copy number variation of proctitis points to altered mitochondrial and DNA repair mechanisms in individuals of European ancestry
    Gita A. Pathak, Renato Polimanti, Talisa K. Silzer, Frank R. Wendt, Ranajit Chakraborty, Nicole R. Phillips
    BMC Cancer.2020;[Epub]     CrossRef
  • MiR-210-3p protects endometriotic cells from oxidative stress-induced cell cycle arrest by targeting BARD1
    Yongdong Dai, Xiang Lin, Wenzhi Xu, Xiaona Lin, Qianmeng Huang, Libing Shi, Yibin Pan, Yinli Zhang, Yunshan Zhu, Chao Li, Lulu Liu, Songying Zhang
    Cell Death & Disease.2019;[Epub]     CrossRef
  • Molecular Signature and Mechanisms of Hepatitis D Virus–Associated Hepatocellular Carcinoma
    Giacomo Diaz, Ronald E. Engle, Ashley Tice, Marta Melis, Stephanie Montenegro, Jaime Rodriguez-Canales, Jeffrey Hanson, Michael R. Emmert-Buck, Kevin W. Bock, Ian N. Moore, Fausto Zamboni, Sugantha Govindarajan, David E. Kleiner, Patrizia Farci
    Molecular Cancer Research.2018; 16(9): 1406.     CrossRef
  • BRCA1 and MDM2 as independent blood-based biomarkers of head and neck cancer
    Aditi Bhowmik, Sambuddha Das, Abhinandan Bhattacharjee, Biswadeep Choudhury, Momota Naiding, Sankar Kumar Ghosh, Yashmin Choudhury
    Tumor Biology.2016; 37(12): 15729.     CrossRef
  • The identification of a novel role for BRCA1 in regulating RNA polymerase I transcription
    Rebecca Johnston, Zenobia D’Costa, Swagat Ray, Julia Gorski, D. Paul Harkin, Paul Mullan, Konstantin I. Panov
    Oncotarget.2016; 7(42): 68097.     CrossRef
  • Differing effects of adjuvant chemotherapy according to BRCA1 nuclear expression in gastric cancer
    Jin Won Kim, Hyun Jin Cho, Miso Kim, Kyung-Hun Lee, Min A. Kim, Sae-Won Han, Do-Youn Oh, Hyuk-Joon Lee, Seock-Ah Im, Tae-You Kim, Han-Kwang Yang, Woo Ho Kim, Yung-Jue Bang
    Cancer Chemotherapy and Pharmacology.2013; 71(6): 1435.     CrossRef
  • Suppression and recovery of BRCA1-mediated transcription by HP1γ via modulation of promoter occupancy
    Jae Duk Choi, Mi Ae Park, Jong-Soo Lee
    Nucleic Acids Research.2012; 40(22): 11321.     CrossRef
  • SUMO1 negatively regulates BRCA1-mediated transcription, via modulation of promoter occupancy
    Mi Ae Park, Yeong-Jae Seok, Gajin Jeong, Jong-Soo Lee
    Nucleic Acids Research.2008; 36(1): 263.     CrossRef
  • Novel Interaction between HPV E6 and BARD1 (BRCA1-Associated Ring Domain 1) and Its Biologic Roles
    Eun-Kyoung Yim, Keun-Ho Lee, Jin Myeong, Seo-Yun Tong, Soo-Jong Um, Jong-Sup Park
    DNA and Cell Biology.2007; 26(10): 753.     CrossRef
  • 14,114 View
  • 98 Download
  • 14 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP